ATE388951T1
Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
Abstract
The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV of formula I, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity. (I)
Term
Term ended
Projected expiry passed 27 June 2022, 4.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
2 priority claims, no other members on record
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| PA200101049 | Denmark | A | |
| PA200200180 | Denmark | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 2748629
Titles2
- German
- DPP-IV-INHIBIERENDE PURIN-DERIVATIVE ZUR BEHANDLUNG VON DIABETES
- English
- DPP-IV INHIBITING PURINE DERIVATIVES FOR THE TREATMENT OF DIABETES
Classification
- CPC, 4
- C07D473/00
- C07D473/02
- A61P3/10
- A61P43/00
- IPC, 9
- C07D473 06
- A61K31 522
- A61K31 55
- A61P3 10
- A61P43 00
- C07D473 00
- C07D473 02
- C07D473 08
- C07D519 00